임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Malignant NeoplasmA Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
리드: 머크(MSD)
- 2상모집 예정· Recurrent Adenoid Cystic CarcinomaSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
협력: 머크(MSD)
- 2상모집 예정· Anal Squamous Cell CarcinomaPhase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
협력: 머크(MSD)
- 2상모집 예정· Urothelial Bladder CancerEnfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC
협력: 머크(MSD)
- 2상모집 예정· Chronic Lymphocytic LeukemiaNemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
협력: 머크(MSD)
- 2상모집 예정· Pulmonary Arterial HypertensionA Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
리드: 머크(MSD)
- 2상모집 예정· Prostate CancerSacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
협력: 머크(MSD)
- 2상모집 예정· Chronic Lymphocytic LeukaemiaA Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
리드: 머크(MSD)
- 2상모집 중· Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaNemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 머크(MSD)
- 2상모집 예정· Recurrent Mantle Cell LymphomaNemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
협력: 머크(MSD)
- 2상모집 예정· HPV-positive Oropharyngeal Squamous Cell CarcinomaRisk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
협력: 머크(MSD)
- 2상모집 중· Lipoprotein(a)A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
리드: 머크(MSD)
- 2상모집 예정· TNBC - Triple-Negative Breast CancerASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
협력: 머크(MSD)
- 2상모집 예정· Metastatic Triple Negative Breast CancersSac-TMT for Active TNBC Brain Metastases
협력: 머크(MSD)
- 2상모집 중· Psoriatic ArthritisStudy to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
리드: 머크(MSD)
- 2상모집 예정· Cervical Cancer by FIGO Stage 2018Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
협력: 머크(MSD)
- 2상모집 예정· Metastatic Pancreatic CancerOlaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer
협력: 머크(MSD)
- 2상모집 예정· Primary GlioblastomaEvaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
협력: 머크(MSD)
- 2상모집 중· Clear Cell Renal Cell CarcinomaPhase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
협력: 머크(MSD)
- 2상모집 중· Squamous Non-small Cell Lung CancerA Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
리드: 머크(MSD) · 협력: 모더나
- 2상모집 중· Neoplasm MalignantA Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
리드: 머크(MSD)
- 2상모집 중단 (진행 중)· Arthritis, RheumatoidA Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
리드: 머크(MSD)
- 2상모집 중· Radiographic Axial SpondyloarthritisA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
리드: 머크(MSD)
- 2상모집 중· Colorectal Adenocarcinoma Metastatic in the LiverPembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중· Malignant NeoplasmA Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
리드: 머크(MSD)
- 2상모집 중· Gastroesophageal Junction (GEJ) AdenocarcinomaAn Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중· Early Alzheimer's DiseaseA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
리드: 머크(MSD)
- 2상모집 중· Recurrent Triple-Negative Breast CancerPembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
협력: 머크(MSD)
- 2상모집 중· Cutaneous SarcomaPembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
협력: 머크(MSD)
- 2상모집 중· Non-small Cell Lung CancerProspective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
협력: 머크(MSD)
- 2상모집 중· MelanomaPLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Hidradenitis SuppurativaStudy to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
리드: 머크(MSD)
- 2상모집 중· Malignant MelanomaA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
리드: 머크(MSD)
- 2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
리드: 머크(MSD)
- 2상모집 중단 (진행 중)· Pulmonary Arterial HypertensionA Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
리드: 머크(MSD)
- 2상모집 중단 (진행 중)· Hypertension, PulmonaryExtension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
리드: 머크(MSD)
- 2상모집 중단 (진행 중)· Human Immunodeficiency Virus Type 1 (HIV-1) InfectionA Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
리드: 머크(MSD)
- 2상모집 중· Muscle Invasive Bladder Urothelial CarcinomaEnfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Gastrointestinal CancerA Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
리드: 머크(MSD)
- 2상모집 중· Lung Neoplasm MalignantPembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
리드: 머크(MSD)
- 2상모집 중· Urinary Bladder NeoplasmsA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
리드: 머크(MSD) · 협력: 모더나
- 2상모집 중· Ovarian CancerNewly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
협력: 머크(MSD)
- 2상모집 예정· Cervical AdenocarcinomaPembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Advanced Solid TumorA Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
협력: 머크(MSD)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.